Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center
- PMID: 24607551
- PMCID: PMC4036533
- DOI: 10.1016/j.bbmt.2014.02.024
Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center
Abstract
Respiratory syncytial virus (RSV) outbreaks in inpatient settings are associated with poor outcomes in cancer patients. The use of molecular epidemiology to document RSV transmission in the outpatient setting has not been well described. We performed a retrospective cohort study of 2 nosocomial outbreaks of RSV at the Seattle Cancer Care Alliance. Subjects included patients seen at the Seattle Cancer Care Alliance with RSV detected in 2 outbreaks in 2007-2008 and 2012 and all employees with respiratory viruses detected in the 2007-2008 outbreak. A subset of samples was sequenced using semi-nested PCR targeting the RSV attachment glycoprotein coding region. Fifty-one cases of RSV were identified in 2007-2008. Clustering of identical viral strains was detected in 10 of 15 patients (67%) with RSV sequenced from 2007 to 2008. As part of a multimodal infection control strategy implemented as a response to the outbreak, symptomatic employees had nasal washes collected. Of 254 employee samples, 91 (34%) tested positive for a respiratory virus, including 14 with RSV. In another RSV outbreak in 2012, 24 cases of RSV were identified; 9 of 10 patients (90%) had the same viral strain, and 1 (10%) had another viral strain. We document spread of clonal strains within an outpatient cancer care setting. Infection control interventions should be implemented in outpatient, as well as inpatient, settings to reduce person-to-person transmission and limit progression of RSV outbreaks.
Keywords: Health care worker; Infection control; Molecular epidemiology; Outpatient clinic; Respiratory syncytial virus.
Copyright © 2014 American Society for Blood and Marrow Transplantation. All rights reserved.
Figures





Similar articles
-
Molecular characterization of strains of respiratory syncytial virus identified in a hematopoietic stem cell transplant outpatient unit over 2 years: community or nosocomial infection?Biol Blood Marrow Transplant. 2008 Dec;14(12):1348-55. doi: 10.1016/j.bbmt.2008.09.012. Biol Blood Marrow Transplant. 2008. PMID: 19041056
-
Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.Antimicrob Resist Infect Control. 2018 Feb 13;7:21. doi: 10.1186/s13756-018-0316-2. eCollection 2018. Antimicrob Resist Infect Control. 2018. PMID: 29449938 Free PMC article.
-
The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit.J Med Virol. 2017 Aug;89(8):1364-1372. doi: 10.1002/jmv.24800. Epub 2017 Mar 22. J Med Virol. 2017. PMID: 28240370
-
Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended.Clin Infect Dis. 2000 Aug;31(2):590-6. doi: 10.1086/313960. Epub 2000 Sep 14. Clin Infect Dis. 2000. PMID: 10987726 Review.
-
Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study.Pediatrics. 1997 Dec;100(6):943-6. doi: 10.1542/peds.100.6.943. Pediatrics. 1997. PMID: 9374561 Review.
Cited by
-
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.Eur J Cancer. 2016 Nov;67:200-212. doi: 10.1016/j.ejca.2016.08.015. Epub 2016 Sep 25. Eur J Cancer. 2016. PMID: 27681877 Free PMC article. Review.
-
Respiratory syncytial virus: an under-recognized healthcare-associated infection.Infect Control Hosp Epidemiol. 2025 May 16;46(6):1-5. doi: 10.1017/ice.2025.88. Online ahead of print. Infect Control Hosp Epidemiol. 2025. PMID: 40376828 Free PMC article.
-
Challenges and opportunities in developing respiratory syncytial virus therapeutics.J Infect Dis. 2015 Mar 15;211 Suppl 1(Suppl 1):S1-S20. doi: 10.1093/infdis/jiu828. J Infect Dis. 2015. PMID: 25713060 Free PMC article.
-
Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.Infect Dis Ther. 2017 Sep;6(3):383-411. doi: 10.1007/s40121-017-0160-3. Epub 2017 Jun 26. Infect Dis Ther. 2017. PMID: 28653300 Free PMC article. Review.
-
Employee influenza vaccination in a large cancer center with high baseline compliance rates: comparison of carrot versus stick approaches.Am J Infect Control. 2015 Mar 1;43(3):228-33. doi: 10.1016/j.ajic.2014.11.025. Am J Infect Control. 2015. PMID: 25728148 Free PMC article.
References
-
- Englund J.A., Sullivan C.J., Jordan M.C. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med. 1988;109:203–208. - PubMed
-
- Boeckh M., Englund J., Li Y. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis. 2007;44:245–249. - PubMed
Publication types
MeSH terms
Grants and funding
- CA18029/CA/NCI NIH HHS/United States
- K23 HL091059/HL/NHLBI NIH HHS/United States
- P01 CA018029/CA/NCI NIH HHS/United States
- L40AI071572/AI/NIAID NIH HHS/United States
- HL9329/HL/NHLBI NIH HHS/United States
- K23 HL096831/HL/NHLBI NIH HHS/United States
- K23 AI103105/AI/NIAID NIH HHS/United States
- HL081595/HL/NHLBI NIH HHS/United States
- K23HL091059/HL/NHLBI NIH HHS/United States
- L40 AI071572/AI/NIAID NIH HHS/United States
- R01 HL081595/HL/NHLBI NIH HHS/United States
- K23HL096831/HL/NHLBI NIH HHS/United States
- K23-AI103105/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials